-
261
Experimentally revised repertoire of putative contingency loci in Neisseria meningitidis strain MC58: evidence for a novel mechanism of phase variation.
Published 2003“…Analysis of the genome sequence of Neisseria meningitidis strain MC58 revealed 65 genes associated with simple sequence repeats. …”
Journal article -
262
Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial
Published 2022“…Outer membrane vesicles (OMV) from Neisseria meningitidis have been used successfully as vaccines against the disease, although they only provide protection against a limited number of the many existing variants. …”
Journal article -
263
Molecular typing methods for outbreak detection and surveillance of invasive disease caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae, a review
Published 2011“…Invasive disease caused by the encapsulated bacteria <em>Neisseria meningitidis</em>, <em>Haemophilus influenzae</em> and <em>Streptococcus pneumoniae</em> remains an important cause of morbidity and mortality worldwide, despite the introduction of successful conjugate polysaccharide vaccines that target disease-associated strains. …”
Journal article -
264
Primary meningococcal conjunctivitis in an adult patient
Published 2023-01-01Subjects: Get full text
Article -
265
Epidemiology of Invasive Meningococcal Disease in Colombia: A Retrospective Surveillance Database Analysis
Published 2023-11-01Subjects: Get full text
Article -
266
Vaccination strategies for the prevention of meningococcal disease
Published 2018-05-01Subjects: “…neisseria meningitidis…”
Get full text
Article -
267
Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countries
Published 2020-10-01Subjects: “…neisseria meningitidis…”
Get full text
Article -
268
Evidence for Multi-Organ Infection During Experimental Meningococcal Sepsis due to ST-11 Isolates in Human Transferrin-Transgenic Mice
Published 2020-09-01Subjects: “…Neisseria meningitidis…”
Get full text
Article -
269
Genomic Analysis of the Evolution and Global Spread of Hyper-invasive Meningococcal Lineage 5
Published 2015-03-01Subjects: “…Neisseria meningitidis…”
Get full text
Article -
270
Immunogenicity and safety among laboratory workers vaccinated with Bexsero® vaccine
Published 2017-03-01Subjects: Get full text
Article -
271
Características epidemiológicas y microbiológicas en casos confirmados de enfermedad meningocócica en Cuba, 1998-2007
Published 2013-08-01Subjects: Get full text
Article -
272
Use of sodC versus ctrA for real-time polymerase chain reaction-based detection of Neisseria meningitidis in sterile body fluids
Published 2013-04-01“…We evaluated the use of a newly described sodC-based real-time-polymerase chain reaction (RT-PCR) assay for detecting Neisseria meningitidis in normally sterile sites, such as cerebrospinal fluid and serum. …”
Get full text
Article -
273
N-terminal amino acid sequences of the major outer membrane proteins from a Neisseria meningitidis group B strain isolated in Brazil
Published 1996-02-01Subjects: “…Neisseria meningitidis group B…”
Get full text
Article -
274
-
275
-
276
Whole genome analysis of Neisseria meningitidis isolates from invasive meningococcal disease collected in the Czech Republic over 28 years (1993-2020).
Published 2023-01-01“…The aim of this study was to define the clonal composition of the Neisseria meningitidis population in the Czech Republic, to determine changes in this population over time and to estimate the theoretical coverage of isolates by MenB vaccines. …”
Get full text
Article -
277
A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.
Published 2007“…We conducted a phase 3 randomized controlled trial looking at the immunogenicity and safety of a novel combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine, Hib-MenC-TT in a 2-, 3-, and 4-month primary infant immunization schedule. …”
Journal article -
278
Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on neisseria meningitidis recombinant porA protein: a comparison in mice
Published 2014“…Neisseria meningitidis lipopolysaccharide (LPS) has adjuvant properties that can be exploited to assist vaccine immunogenicity. …”
Journal article -
279
Potential coverage of the 4CMenB vaccine against invasive serogroup B Neisseria meningitidis isolated from 2009 to 2013 in the Republic of Ireland
Published 2018“…Neisseria meningitidis is a common cause of bacterial meningitis in children and young adults worldwide. …”
Journal article -
280
Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties.
Published 2014“…Factor H binding protein (fHbp) is one of the main antigens of the 4-component meningococcus B (4CMenB) multicomponent vaccine against disease caused by serogroup B Neisseria meningitidis (MenB). fHbp binds the complement down-regulating protein human factor H (hfH), thus resulting in immune evasion. fHbp exists in 3 variant groups with limited cross-protective responses. …”
Journal article